Power Comes From Within
RelieVRx (relievrx.com) scores 72 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 32nd percentile of 19961 Healthcare brands.
RelieVRx is an FDA-authorized, immersive virtual reality therapy device used at home to treat chronic lower back pain. It applies established pain management techniques such as cognitive behavioral therapy (CBT) and relaxation exercises through a self-guided VR program. The product is positioned as a non-pharmacologic, non-invasive alternative to traditional pain treatments and is marketed to patients, healthcare providers, health plans, and workers' compensation payors seeking evidence-based, drug-free chronic pain management solutions.
| Brand Name | RelieVRx |
|---|---|
| Domain | relievrx.com |
| Industry | Healthcare, Technology |
| Main Competitors | Hinge Health (84/100), Sword Health (86/100), Kaia Health (80/100), XRHealth (70/100), Omada Health (83/100) |
Moz Domain Authority 33/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "RelieVRx is now FDA-authorized. RelieVRx is an immersive multisensory virtual reality therapy used at home for the treatment of chronic lower back pain." (Meta description: 23 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Next.js.
Social footprint: verified profiles on Facebook, LinkedIn, X (Twitter), Instagram, GitHub; no detected presence on YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is RelieVRx?", Claude could identify the brand as of October 2026. RelieVRx is a prescription-use virtual reality therapeutic developed by AppliedVR, authorized by the FDA to help manage chronic lower back pain through cognitive behavioral therapy and relaxation techniques delivered via a VR headset. Best known for being the first FDA-authorized VR therapeutic for chronic pain management.
When asked "Best brands similar to RelieVRx?", Claude would recommend RelieVRx as of October 2026. It's a notable and well-documented example of prescription digital therapeutics for pain management, so it would come up in discussions of VR based healthcare solutions.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
RelieVRx's main competitors in Healthcare: Hinge Health (84/100), Sword Health (86/100), Kaia Health (80/100), XRHealth (70/100), Omada Health (83/100).
Sources: Brand Analyzer scan
RelieVRx offers an immersive, multisensory virtual reality therapy device intended for in-home use to treat chronic lower back pain. The therapy program incorporates established pain management approaches such as cognitive behavioral therapy (CBT) and relaxation techniques delivered through a self-guided VR format.
Sources: RelieVRx official site
RelieVRx is an FDA-authorized, immersive, multisensory virtual reality therapy device used at home for the treatment of chronic lower back pain. It is classified as a medical device rather than a general consumer VR product, and its use is documented in clinical trial research.
Sources: RelieVRx official site
RelieVRx has limited AI-search visibility, scoring 26/100 on Brand Analyzer's AI visibility composite (visibility 13, trust 22, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: RelieVRx official site
RelieVRx delivers a self-guided virtual reality therapy program designed to help patients manage and reduce chronic lower back pain. It applies established pain management techniques, including cognitive behavioral therapy (CBT) and relaxation exercises, through an in-home, immersive VR experience, offering a non-drug alternative to pain management.
Sources: RelieVRx official site
RelieVRx has received FDA authorization, indicating it has met regulatory standards for safety and effectiveness as a medical device. It is also described as clinically proven to deliver significant, lasting reduction of chronic lower back pain, which supports its credibility as a non-pharmacologic therapy option backed by clinical evidence.
Sources: RelieVRx official site
RelieVRx scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: RelieVRx official site
RelieVRx is known for being the first FDA-authorized in-home virtual reality treatment clinically proven to produce significant, lasting reduction in chronic lower back pain. It is recognized for combining VR technology with evidence-based pain management methods like CBT and relaxation techniques in a non-pharmacologic, non-invasive format.
Sources: RelieVRx official site
RelieVRx can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: RelieVRx official site
RelieVRx is used by patients suffering from chronic lower back pain, including veterans. It is also targeted toward healthcare providers, health plans, and workers' compensation payors who are seeking non-drug, evidence-based treatment options for chronic pain management.
Sources: RelieVRx official site
RelieVRx scores 26/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
RelieVRx has a weak AI-visibility profile at 26/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (13/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 33/100 and thin schema.org structured data. In a live check, Claude could already identify RelieVRx from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to RelieVRx: Hound (72/100), Relevant (72/100), Renée Fleming (72/100), Repertoire Immune Medicines (72/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.